LinkedIn IconTwitter Icon
14-16 November 2017
The Westin Grand Munich, Germany

Delivering Maximum Clinical Benefit
Through Immune Checkpoint Modulation

Returning for a 3rd year, the ICI Europe Summit will unite this burgeoning field to once again provide you the insight and connections to develop more clinically impactful checkpoint modulation therapeutics.

Through a combination of data-driven case studies and interactive experience sharing sessions, join us to receive practical insights on what it takes to develop the next generation of ICI drugs.

Discover the latest insights into novel checkpoint pathways, more predictive preclinical models, optimal combination strategies and emerging stratification biomarkers.

Don’t miss this opportunity to join the leaders in the field, receive insights that will enable you to make the right decisions with your IO pipeline, and lay the foundations for your future success.

Find out more.

“The talks were high quality and the interaction among participants was excellent.”

Genentech

“Strong program, great speakers and a genuine focus on identifying solutions.”

Novartis

"A great opportunity for sharing the latest science, networking, and establishing new collaborations."

Boehringer Ingelheim

Benefits of Attending:
Benefits Bullets